Diffuse large B-cell lymphoma developing following treatment of Waldenstrom's macroglobulinaemia: spontaneous resolution upon cessation of fludarabine.
Lim
Ziyi
Z
Cassells
Rachael
R
Giles
Andrew
A
Cheow
Heok Keong
HK
Mir
Naheed
N
D000368:Aged; D000970:Antineoplastic Agents / Q000009:adverse effects*; D004248:DNA (Cytosine-5-)-Methyltransferases / Q000037:antagonists & inhibitors; D006801:Humans; D016393:Lymphoma, B-Cell / Q000139:chemically induced* / Q000188:drug therapy; D016403:Lymphoma, Large B-Cell, Diffuse / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D016896:Treatment Outcome; D014740:Vidarabine / Q000009:adverse effects / Q000031:analogs & derivatives*; D008258:Waldenstrom Macroglobulinemia / Q000150:complications* / Q000188:drug therapy
D000970:Antineoplastic Agents; D004248:DNA (Cytosine-5-)-Methyltransferases; D014740:Vidarabine; C024352:fludarabine